ETR:AFX - Carl Zeiss Meditec Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started €75.15 +0.45 (+0.60 %) (As of 01/18/2019 04:00 PM ET)Previous Close€75.15Today's Range€74.00 - €75.8052-Week Range€37.53 - €55.25Volume103,661 shsAverage Volume94,405 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionAnalyst RatingsChartHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery. This segment also offers optical coherence tomography devices, perimeters, fundus cameras, slit lamps, and therapeutic and refractive lasers for the diagnosis and treatment of various eye diseases, such as refraction, glaucoma, and other retinal diseases. The Microsurgery segment provides surgical microscopes and visualization solutions for neuro, spinal, dental, and plastic and reconstructive surgeries, as well as for ear, nose, and throat surgery; and products for surgical treatment of tumors or vascular diseases, such as aneurysms. Carl Zeiss Meditec AG serves ophthalmologists and optometrists, as well as physicians and surgeons in hospitals and outpatient surgery centers. The company was founded in 2002 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG. Receive AFX News and Ratings via Email Sign-up to receive the latest news and ratings for AFX and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange ETR Industry Diagnostics & Research Sub-IndustryN/A SectorMedical Current SymbolETR:AFX Previous Symbol CUSIPN/A Webwww.zeiss.commeditec-aghome.html Phone+49-3641-2200Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees3,048 Outstanding SharesN/AMarket Cap$0.00 OptionableNot Optionable Carl Zeiss Meditec (ETR:AFX) Frequently Asked Questions What is Carl Zeiss Meditec's stock symbol? Carl Zeiss Meditec trades on the ETR under the ticker symbol "AFX." What price target have analysts set for AFX? 9 brokers have issued twelve-month price targets for Carl Zeiss Meditec's shares. Their predictions range from €58.00 to €78.50. On average, they anticipate Carl Zeiss Meditec's share price to reach €68.44 in the next year. This suggests that the stock has a possible downside of 8.9%. View Analyst Price Targets for Carl Zeiss Meditec. What is the consensus analysts' recommendation for Carl Zeiss Meditec? 9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Carl Zeiss Meditec in the last year. There are currently 3 sell ratings, 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Carl Zeiss Meditec. Has Carl Zeiss Meditec been receiving favorable news coverage? Press coverage about AFX stock has been trending positive this week, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Carl Zeiss Meditec earned a news impact score of 2.2 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the stock's share price in the near future. Who are some of Carl Zeiss Meditec's key competitors? Some companies that are related to Carl Zeiss Meditec include 3D Signatures (DXD), BioNano Genomics (BNGOU), Cambridge Cognition (COG), Carl Data Solutions (CRL), Co-Diagnostics (CODX), Deepmatter Group (DMTR), Dorsavi (DVL), EPIGENOMICS AG/S (EPGNY), Eternity Healthcare (ETAH), Genedrive (GDR), GeneNews (GEN), Imaging Dynamics (IDL), LED Medical Diagnostics (LMD), Lexagene (LXG) and MaxCyte (MXCT). Who are Carl Zeiss Meditec's key executives? Carl Zeiss Meditec's management team includes the folowing people: Dr. Ludwin Monz, Pres, CEO & Chairman of Management Board (Age 56)Mr. Justus Felix Wehmer, CFO & Member of the Management Board (Age 54)Mr. Jan Willem de Cler, Head of Surgical Ophthalmology & Member of Management BoardMr. Sebastian Frericks, Director of Investor RelationsMr. Martin Wiechmann, Head of the Planetarium Bus. Unit What is Carl Zeiss Meditec's stock price today? One share of AFX stock can currently be purchased for approximately €75.15. What is Carl Zeiss Meditec's official website? The official website for Carl Zeiss Meditec is https://www.zeiss.com/meditec-ag/home.html. How can I contact Carl Zeiss Meditec? Carl Zeiss Meditec's mailing address is Goeschwitzer Strasse 51-52, JENA, 07745, Germany. The company can be reached via phone at +49-3641-2200. MarketBeat Community Rating for Carl Zeiss Meditec (ETR AFX)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 148 (Vote Outperform)Underperform Votes: 147 (Vote Underperform)Total Votes: 295MarketBeat's community ratings are surveys of what our community members think about Carl Zeiss Meditec and other stocks. Vote "Outperform" if you believe AFX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AFX will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/19/2019 by MarketBeat.com StaffFeatured Article: How Do Front-End Loads Impact an Investment?